stockrow
Friday 6 November 2026
Export INNV’s income statement to Excel — free account
InnovAge Holding Corp.
INNV Healthcare Medical Care Facilities
InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.
- Revenue
- +12.1%
- EPS
- +155.0%
- Free cash flow
- +18,885.6%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
9.04
0.75
−7.66%
Follow INNV
Alert me
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 4 | 3 | 4 | 5 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
4.58 | 2.23 | 2.65 | 3.28 | 3.18 | 9.83 | — | — | — |
P/S ratio |
1.62 | 0.59 | 0.90 | 1.48 | 0.85 | 4.13 | 4.64 | 4.64 | — |
Altman Z″-Score (non-manufacturers) |
0.32 | 0.00 | 0.80 | 1.18 | 3.21 | 3.91 | 3.17 | 2.03 | — |
P/FCF ratio |
31.73 | 21.57 | 0.00 | 0.00 | 0.00 | 0.00 | 141.37 | 141.37 | — |
Beneish M-Score |
(3.10) | (3.32) | (1.45) | (3.27) | (2.45) | (3.03) | (2.82) | — | — |
P/Operating CF |
75.53 | 55.50 | 365.69 | 77.33 | 183.03 | 277.88 | 162.85 | 162.85 | — |
P/B ratio |
6.73 | 2.10 | 2.47 | 3.37 | 1.75 | 7.73 | 0.00 | 0.00 | — |
Price to Tangible BV |
17.20 | 5.43 | 5.15 | 5.89 | 2.85 | 12.53 | 0.00 | 0.00 | — |
EV/Sales |
1.54 | 0.54 | 0.86 | 1.34 | 0.70 | 3.94 | 5.01 | 5.01 | — |
EV/EBITDA |
62.08 | 0.00 | 0.00 | 0.00 | 49.32 | 2,478.95 | 113.77 | 113.77 | — |
EV/Operating CF |
23.53 | 14.02 | (17.89) | 45.72 | 17.97 | (332.69) | 70.60 | 70.60 | — |
EV/FCF |
30.05 | 19.90 | (13.68) | (141.15) | (34.13) | (100.09) | 152.51 | 152.51 | — |
Quick Ratio |
0.92 | 0.88 | 1.11 | 1.33 | 2.16 | 3.08 | 2.12 | 1.39 | — |
Current Ratio |
1.05 | 1.07 | 1.25 | 1.45 | 2.29 | 3.19 | 2.18 | 1.43 | — |
Net Debt/EBITDA |
(3.47) | 3.94 | 6.52 | 2.73 | (10.36) | (121.57) | 1.62 | 2.66 | — |
Debt/Assets |
10.10% | 12.76% | 14.25% | 14.41% | 14.66% | 15.15% | 52.84% | 53.16% | 0.00% |
Debt/Equity |
0.24 | 0.28 | 0.28 | 0.27 | 0.24 | 0.24 | 2.01 | 2.37 | — |
Asset Turnover |
1.83 | 1.59 | 1.37 | 1.23 | 1.29 | 1.36 | 1.47 | 2.56 | — |
Operating CF/Net income |
(25.51) | (1.08) | 1.73 | (0.50) | (4.19) | 0.17 | 1.67 | 1.32 | — |
Capex/Depreciation |
(0.48) | (0.31) | (0.41) | (1.47) | (2.66) | (1.46) | (0.99) | (1.46) | — |
Interest Coverage |
0.61 | (6.45) | (5.76) | (32.45) | (1.74) | (0.73) | 3.48 | 4.14 | — |
| (1.06%) | (11.76%) | (7.36%) | (12.70%) | (1.92%) | (19.60%) | 27.78% | 22.35% | — | |
| (0.47%) | (5.64%) | (3.83%) | (7.24%) | (1.20%) | (9.34%) | 6.80% | 10.78% | — | |
ROIC |
1.06% | (9.34%) | (5.73%) | (14.68%) | (1.17%) | (3.54%) | 15.18% | 11.62% | — |
Return on Tangible Assets |
(1.44%) | (16.90%) | (9.38%) | (15.71%) | (2.09%) | (13.96%) | 13.63% | 14.27% | — |
Average Days of Receivables |
16.84 | 16.97 | 24.58 | 13.05 | 22.29 | 21.74 | 30.92 | 43.12 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
20.29% | 17.60% | 17.84% | 19.66% | 18.01% | 24.23% | 13.66% | 13.90% | — |
Intangible Assets out of Total Assets |
0.26 | 0.28 | 0.26 | 0.23 | 0.23 | 0.25 | 0.30 | 0.34 | 0.00 |
Share Based Compensation of Revenue |
0.71% | 0.89% | 0.89% | 0.67% | 0.54% | 0.26% | 0.10% | 0.16% | — |
Graham Net Nets |
(0.06) | (0.23) | (0.14) | (0.05) | 0.04 | 0.02 | 0.04 | 0.04 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(0.17%) | (6.23%) | (3.17%) | (4.13%) | (0.91%) | (1.73%) | (0.74%) | (0.74%) | — |
Free Cash Flow Yield |
3.15% | 4.64% | (7.04%) | (0.64%) | (2.42%) | (0.95%) | 0.71% | 0.71% | — |
Revenue per Share |
7.29 | 6.31 | 5.62 | 5.07 | 5.16 | 5.16 | 4.28 | 3.52 | — |
Operating CF per Share |
0.48 | 0.24 | (0.27) | 0.15 | 0.20 | (0.06) | 0.33 | 0.20 | — |
Capex per Share |
(0.08) | (0.05) | (0.06) | (0.17) | (0.28) | (0.16) | (0.09) | (0.11) | — |
Free Cash Flow per Share |
0.40 | 0.20 | (0.33) | (0.02) | (0.08) | (0.22) | 0.24 | 0.09 | — |
Cash per Share |
1.04 | 0.78 | 0.76 | 1.28 | 1.36 | 1.65 | 0.86 | 0.46 | — |
Shareholders Equity per Share |
1.76 | 1.76 | 2.04 | 2.23 | 2.50 | 2.76 | 0.81 | 0.62 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.76 | 1.76 | 2.04 | 2.23 | 2.50 | 2.76 | 0.81 | 0.62 | — |
Free Cash Flow |
54.12 | 26.60 | (44.81) | (3.12) | (10.94) | (27.09) | 32.15 | 11.42 | — |
Working Capital |
10.42 | 11.30 | 34.54 | 66.78 | 135.65 | 172.37 | 90.30 | 35.99 | — |
Capital Expenditures |
(10.59) | (6.26) | (7.91) | (23.35) | (38.24) | (19.54) | (11.67) | (14.49) | — |
Net Current Asset Value |
(104.32) | (112.84) | (96.91) | (50.04) | 23.83 | 60.16 | (134.95) | (162.34) | — |
EV/EBIT |
581.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.03 | 0.05 | 0.03 | 0.02 | 0.03 | — |
Price to Operating Income |
614.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.13 | 0.12 | 0.10 | 0.08 | 0.08 | 0.09 | 0.12 | 0.10 | — |
Cash ROIC |
12.40% | 6.47% | (9.78%) | (0.56%) | (1.81%) | (4.33%) | 7.33% | 3.40% | — |
Accounts Receivable Turnover |
23.19 | 18.74 | 20.09 | 20.46 | 17.33 | 14.83 | 11.01 | 9.04 | — |
Accounts Payable Turnover |
7.93 | 10.59 | 11.45 | 11.12 | 13.59 | 15.15 | 14.38 | 11.99 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
55.26 | 40.02 | 32.04 | 34.17 | 32.76 | 25.47 | 24.75 | 31.21 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
42.67 | 45.56 | 38.02 | 33.64 | 40.33 | 43.02 | 51.53 | 51.53 | — |
Average Payables |
96.05 | 66.10 | 55.20 | 52.75 | 41.46 | 30.62 | 29.61 | 29.61 | — |
Average Assets |
542.12 | 537.26 | 557.51 | 561.48 | 543.67 | 470.69 | 386.43 | 181.62 | — |
Average Common Equity |
238.33 | 257.75 | 289.85 | 320.28 | 339.72 | 224.36 | 94.60 | 87.60 | — |
Columns are period end dates · fundamentals updated 5 Nov 2026